Showing papers by "Charles E. Rupprecht published in 1993"

Detection of antibodies against Borna disease virus in sera and cerebrospinal fluid of horses in the USA

Abstract: Sera from 295 horses in the USA were examined by an indirect immunofluorescence assay and Western blot assays to determine the prevalence of Borna disease virus infection. Eight (2.7 per cent) of the samples were positive in both assays, and 18 (6.1 per cent) were positive only in the Western blot assay. The indirect fluorescence titres ranged from 1:20 to 1:80 of antibodies recognising the virus-specific antigen from Borna disease virus-infected cells. The purified virus-specific proteins isolated from infected rat brains were recognised by positive equine serum samples after immunostaining by a Western blot technique. Information obtained from the owners about the history of the seropositive horses revealed that they were either clinically normal or had a pathological diagnosis of disease unrelated to Borna disease. This is the first report of the detection of antibodies to Borna disease virus in horses in the USA. The disease may be more widespread in a subclinical form, with very long incubation periods, and may not necessarily be restricted to historically endemic areas.

A vaccinia-vectored rabies vaccine field trial : ante-and post-mortem biomarkers

Abstract: During the field safety evaluation of a vaccinia-rabies glycoprotein recombinant virus vaccine for wildlife, two biomarkers were used to identify potential contact with vaccine-laden baits. Tetracycline, a commonly used and reliable calciphilic tissue marker, was included in a fish-meal polymer bait matrix and was evaluated from post-mortem bone samples. Additionally, an ante-mortem marker was needed to identify, for prospective study, raccoons which had contacted baits and thus, potentially, vaccine. Sulfadimethoxine (SDM) was included in an attractant slurry surrounding the bait, as a novel short-term seromarker. Preliminary laboratory studies in raccoons demonstrated SDM residues for up to one week following ingestion of a single 250 mg dose. During the first six days after bait distribution, 49 individual raccoons were live-trapped in the vaccination area. SDM was detectable in 38 of 49 (77.5%) serum samples. Similarly, 47 of 56 (83.9%) bone samples from raccoons collected in the vaccination area throughout the twelve-month study were tetracycline-positive. Conversely, none of the serum samples (n = 12) from the first six days of the trial nor any of the bone samples (n = 34) from raccoons in the surveillance area were biomarker-positive.

Experimental Toxoplasma gondii infection in raccoons (Procyon lotor).

Abstract: Six raccoons (Procyon lotor) without detectable Toxoplasma gondii antibodies were used. Four raccoons were inoculated orally (2 with oocysts and 2 with tissue cysts) with ME49 strain of T. gondii and 2 raccoons were not inoculated with T. gondii. All raccoons remained clinically normal. Raccoons were killed between 59 and 61 days after inoculation and portions of their heart, skeletal muscle, and brain were digested in pepsin solution, and homogenates were bioassayed in mice. Toxoplasma gondii was isolated from all 4 inoculated raccoons; from the heart of 3, skeletal muscles of 2 and the brain of none. All 4 inoculated raccoons developed antibody titers > or = 1:1,600 in the modified direct agglutination test (MAT) using whole formalinized tachyzoites. Toxoplasma gondii antibody titers of the raccoons not inoculated with T. gondii remained < 1:25, and T. gondii was not isolated from their tissues. It was concluded that muscle tissue from multiple sites including the heart was the tissue of choice for conducting parasitologic surveys for T. gondii in raccoons. Evaluation of the sera of the experimentally infected raccoons in the Sabin-Feldman dye test, latex agglutination test, and the indirect hemagglutination tests indicated that the MAT detected antibodies faster and in higher titers than did the other serological tests.